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  The present study was undertaken to evaluate porous 
hydroxyapatite (HAp), the powder of which was prepared 
by a novel aqueous solution combustion technique, as a 
bone substitute in healing bone defects in vivo, as assessed 
by radiologic and histopathologic methods, oxytetracycline 
labeling, and angiogenic features in Bengal goat. Bone 
defects were created in the diaphysis of the radius and 
either not filled (group I) or filled with a HAp strut (group 
II). The radiologic study in group II showed the presence 
of unabsorbed implants which acted as a scaffold for new 
bone growth across the defect, and the quality of healing 
of the bone defect was almost indistinguishable from the 
control group, in which the defect was more or less 
similar, although the newly formed bony tissue was more 
organized when HAp was used. Histologic methods 
showed complete normal ossification with development of 
Haversian canals and well-defined osteoblasts at the 
periphery in group II, whereas the control group had 
moderate fibro-collagenization and an adequate amount 
of marrow material, fat cells, and blood vessels. An 
oxytetracycline labeling study showed moderate activity of 
new bone formation with crossing-over of new bone 
trabeculae along with the presence of resorption cavities 
in group II, whereas in the control group, the process of 
new bone formation was active from both ends and the 
defect site appeared as a homogenous non-fluoroscent 
area. Angiograms of the animals in the control group 
showed uniform angiogenesis in the defect site with 
establishment of trans-transplant angiogenesis, whereas in 
group II there was complete trans-transplant shunting of 
blood vessel communication. Porous HAp ceramic 
prepared by an aqueous combustion technique promoted 
bone formation over the defect, confirming their biologic 
osteoconductive property.
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Introduction 
  Although bone tissues are capable of regenerative growth, 
the repair process is inadequate in many clinical and 
pathologic situations, including massive bone loss caused by 
trauma and tumor resection, as well as the reconstructive 
surgery required to correct developmental deformities. The 
lost bone can be replaced by endogenous or exogenous bone 
tissues, which is associated with several disadvantages. The 
properties required for ideal bone substitutes include 
biocompatibility, biodegradability, ability to provide struc-
tural support, capacity to serve as drug carriers, ease of use in 
clinical practice, and an affordable cost/benefit ratio 
[8,22,31]. Due to the limited availability and donor site 
morbidity of bone autografts, and the risk of possible 
immune responses, disease transmission, and the cost of 
allografts, the use of synthetic bioactive materials opens new 
possibilities for clinical application, mainly in orthopaedics 
and dentistry [5,31,38,42]. 
  A number of materials, such as metals, metal alloys, 
collagen, carbon-based materials, polymers, ceramics, and 
composites of the above materials have been recommended 
to fill and reconstruct bone defects, but none have been 
shown to be ideal. However, metals are being widely used for 
major load-bearing orthopedic applications [28]. The 
materials have many limitations, though, due to unfavour-
able corrosion properties, wear, encapsulation by dense 
fibrous tissues to develop improper stress distribution, 
and/or adverse tissue reactions [17]. Several non-metallic 
materials have been proposed for reconstruction of bone, but 
none have been found to be suitable for wide application in 
clinical conditions. Biocompatibility, along with biodegra-
dability and suitable mechanical properties of materials, are 
essential prerequisites for mimicking natural bone, which 
unfortunately exists in a small group of materials. Although 
autogenous bone grafts are still considered the gold standard 
for bone replacement, and allogenic bone grafts are widely 
used, several ceramic biomaterials have been developed as 
synthetic bone substitutes, thus challenging their supremacy. 　
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Fig. 1. Flow chart for the aqueous solution combustion technique
for preparation of the nano-HAp.
  For the current study, calcium-phosphate ceramics, such as 
hydroxyapatite (HAp), have been used because their 
chemical composition is closely related to that of the mineral 
phase of bone [19]. These ceramics are adequately 
biocompatible [10] and do not induce adverse local tissue 
reactions, immunogenicity, or systemic toxicity. Furthermore, 
because this material is osteoconductive, it acts as a support 
for new bone formation within the pore sites [24], which are 
deliberately generated in the structure. However, depending 
on the preparation technique, the material exhibits gross 
different powder characteristics, microstructure, and 
associated mechanical and biologic properties. When 
nano-sized particles below 100 nm of HAp are concerned, it 
is still a challenge to synthesize the same via a simple 
method. Moreover, for repair and reconstruction of diseased 
or damaged bones or tissues, a biphasic calcium phosphate 
(BCP) composed of a suitable percentage of HAp and β- 
tri-calcium phosphate (β-TCP) are thought to be near the 
ideal solution for this remodeling of bone. The first studies of 
LeGeross et al. [23] on BCP with varying HAp/β-TCP 
demonstrated that the bioactivity of these ceramics may be 
controlled by manipulating the HAp/β-TCP ratios. Although 
various routes have been developed to synthesize HAp 
powders [16], only a few reports are available concerning the 
production of β-TCP [20]. For the synthesis of both 
materials, the most commonly adapted technique is wet 
chemical precipitation [2], followed by calcinations. We 
have successfully synthesized a series of BCP composition 
with varied HAp and β-TCP content by using a novel 
aqueous combustion technique. This processing technique is 
often adapted for the rapid preparation of a variety of oxide 
ceramic powders [20]. The process involves an exothermic, 
usually very rapid and self-sustaining chemical reaction 
between the desired metal salts (oxidizer), preferably 
nitrates, and a suitable organic fuel, such as urea, glycine, 
carbohydrazide, and citric acidin an aqueous solution. The 
reaction is initiated at a fairly low temperature followed by 
rapid cooling, and this in turn leads to nucleation of 
crystallites without much growth. The reaction between the 
oxidizer and fuel releases large amounts of reaction heat that 
is utilized to synthesize the desired materials in situ and the 
large volume of gas evolved disintegrates the high purity 
products to friable agglomerates of very fine particulates.
  The purpose of the present study was to evaluate porous 
HAp, the powders of which were prepared by a novel 
aqueous solution combustion technique, as a bone substitute 
in healing bone defects.
Materials and Methods
Synthesis of nano-crystalline HAp by an aqueous 
solution combustion method
  Calcium nitrate tetrahydrate (S.D. Fine-Chem, India) and 
di-ammonium hydrogen ortho-phosphate (DAP; S.D. 
Fine-Chem, India) were used as raw materials for the 
preparation of calcium phosphate powders. Urea (Glaxo, 
India) and glycine (Glaxo, India), both A.R. grade, were 
used as the fuel. For synthesizing HAp, aqueous stock 
solutions of calcium nitrate tetrahydrate (2.72 M) and DAP 
(2.09 M) were first mixed slowly with continuous stirring; 
subsequently concentrated nitric acid was added dropwise to 
dissolve the resulting white precipitate. A predetermined 
amount of solid fuel was added to the clear solution and 
homogenized by stirring with a magnetic stirrer for 30 min. 
at room temperature. One glass ceramic-coated mild steel 
(dia. ∼80 mm, volume 130 ml) container containing the 
solution was introduced into a muffle furnace preheated to 
the desired temperature (300-700oC). A stainless steel wire 
mesh was put on the reaction container to reduce particle loss 
through aerosol formation. Immediately after placement in 
the furnace, the mixed solution started to boil, followed by 
the evolution of a large volume of gases. The mass then 
frothed and swelled to yield foam, from where a flame 
appeared and burned with incandescence. At the initiation of 
ignition, the furnace was switched off. The heat evolved 
during the reaction sustained itself and proceed to com-
pletion without requiring any further heat from an external 
source. The general flowchart for the process is shown in 
Fig. 1. Details of the in vitro characterization of the prepared 
powder are beyond the scope of this article, but can be found 
elsewhere [12]. This powder has been used for the following 
studies.
Fabrication of porous HAp
  In the present study, porous (35-40% by volume) HAp was 
fabricated by using β-naphthalene and polyvinyl alcohol 
(S.D. Fine-Chem, India) as a combustible organic material. 
HAp powder was milled separately with oleic acid surfactant 
and a pre-calculated amount of β-naphthalene. 
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Fig. 2. (A) Scanning electron micrograph of the porous specimen of HAp before implantation in goats. (B) Histogram of pore size dis-
tribution patterns of the HAp specimen.
Rectangular- shaped (12 × 5 × 3 mm3) blocks were uniaxially 
cold-compacted with low pressure, and subsequently cold 
iso-statically pressed at 100 MPa for homogeneous 
densification. All specimens were slowly dried at 80oC for 3 
days. Finally, HAp specimens were sintered at 1,250oC for 2 
h. Archimedes’ principle using water as the immersing 
medium was used to calculate the density and apparent 
porosity of the sintered specimens. Scanning electron 
microscopy (SEM) and mercury intrusion porosimetry 
(MIP) were used to obtain the pore shape, size, morphology, 
and distribution of the specimens. Fig. 2A shows the SEM 
photomicrograph of the porous strut with a tag of 5 μm, 
while Fig. 2B shows the histogram based on the MIP data for 
distribution of the pores in the struts. The porous struts were 
initially pasteurized with distilled water and subsequently 
autoclaved at 121oC for 30 min. before implantation. 
Archimedes' principle using water as the immersing medium 
was used to calculate the density and apparent porosity of the 
sintered specimens and found to be 2.04 g/ml and 35.2% on 
an average, respectively.
Animal experimentation
  Animal experimentation was carried out following the 
procedures conforming to the standards of the Institutional 
Animal Ethical Committee of the West Bengal University of 
Animal and Fishery Sciences. Twelve black Bengal goats of 
both genders, weighing 10-12 kg, were randomly distributed 
into 2 groups of 6 animals each, as follows: control (group I), 
in which the bone defect was not treated and the test 
specimen (group II), in which porous HAp blocks were 
inserted within the bone defect. Under standard aseptic 
conditions and sedation with xylazine hydrochloride (0.05 
mg/kg body weight; Indian Immunologicals, India) in 
animals which had received atropine and local 2% ligno-
caine hydrochloride (Neon Laboratories, India), a 3 cm 
longitudinal skin incision was made on the lateral side of the 
radius bone. The implant sites (1 × 0.5 cm) were prepared 
using a micro-motor dental drill after exposing the cortical 
bone followed by irrigation with sterile normal saline. In the 
controls (group I), the defect was left as such without any 
implant, while in group II, HAp blocks were placed in the 
defect sites. The implants were secured in position by 
suturing the periosteum, muscle, subcutaneous tissue, and 
skin in layers. Postoperatively, all the animals received 
cefotaxime sodium (250 mg I/M twice daily; Mapra India, 
India) and injectable meloxicam (0.5 ml once daily for 5 
days; Intas Pharmaceuticals, India) with daily dressing 
changes of the surgical wounds.
Local inflammatory reaction and healing of the wound
  Local inflammatory reactions and healing of the wounds 
were assessed by visual and manual examinations from the 
day of surgery up until the 90th day postoperatively.
Radiological examination
  Radiographs were obtained of the operated forelimb 
immediately after implantation and subsequently on days 
21, 30, 60, and 90 postoperatively to assess the status of the 
implant, the host-bone reaction to the implant, and new bone 
formation. X-rays were also obtained after light sedation 
using xylazine hydrochloride (0.05 mg/kg body weight).
Histological study
  The implanted ceramic blocks, along with the surrounding 
bones, were collected from the animals on day 90 post-
operatively. The bone sections with both normal and 
implanted areas were prepared by decalcification following 
a standard technique; 4 μm sections were cut and stained 
with hematoxylin and eosin to observe the status of the bone 
implants and the cellular response of host bone to the 
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Fig. 3. Radiographs of the control site obtained on day 0, 21, 30,
60, and 90 post-operatively.
Fig. 4. Radiographs of the HAp-implanted site obtained on day 0,
21, 30, 60, and 90 post-operatively.
implants.
Oxytetracycline labeling study
  Fluorochrome (oxytetracycline dehydrate; Pfizer India, 
India), at a dose of 50 mg/kg body weight, was given on days 
77, 78, 85, and 86 (2-6-2 i.e. two injections on day 77 and 78 
and after 6 days another two injections on days 85 and 86) 
post-operatively for double-toning of new bone. Undecalcified 
ground sections were prepared [27] from the implanted 
segments of bone and the sections were ground to 20 μm 
thickness using different grades of sand paper. The ground- 
undecalcified sections were observed under ultraviolet 
incidental light with an Orthoplan microscope (Excitation 
filter, BP- 400 range; Leitz, USA) for tetracycline labeling to 
determine the amount and source of newly formed bone.
Angiographic study
  Radial angiography was performed by making a 4-5 cm 
skin incision aseptically on the medial aspect of the thigh 
under xylazine hydrochloride sedation and local infiltration 
analgesia with 2% lignocaine hydrochloride on day 90 
postoperatively. The radial arteries were located, exteriorized, 
and catheterized using polyethylene catheters connected to a 
syringe containing 15 ml sodium iothalmate (Mallinckradt, 
USA). The contrast material was infused with regular gentle 
digital pressure and radiographs were taken at 14 mAs, 50 
kVP, and 90 cm FFD. The catheter was removed and the 
puncture of the artery was sutured with 4-0 chromic catgut, 
and finally the skin wound was closed. For better visuali-
zation of the arteries, one test limb from each group was 
collected after euthanizing the animal at the end of the 
experiment; the limb was perfused with lead oxide suspen-
sion (20% W/V) in a manner similar to that used to examine 
the vascular response of host bone and surrounding tissues in 
the implanted area and visualization of the implant.
Results
Local inflammatory reactions and healing of the 
wound
  No marked inflammatory reactions were observed in the 
control and experimental groups following placement of 
bioceramic implants up to the 90th day postoperatively. 
Weight-bearing capacity in each animal gradually improved, 
as signs of inflammation subsided (within 10 days). There 
was no adverse local effect, such as marked hematoma or 
edema, during the early postoperative period. Wound 
healing was uneventful in all cases and the sutures were 
removed on the 10th postoperative day. The implants were 
clinically stable in the bone.
Radiological observations
  On day 0 in group I (control), the radiographs showed the 
cortical defect devoid of any implant, resulting in a 
radiolucent gap. On day 21, the radiographs revealed a 
minimal periosteal reaction and smoothing edges with 
oval-shaped corners of the cortical bone defects. On day 30, 
radiographs indicated a substantial reduction in the gap size, 
which was in the process of obliteration by hard tissue 
materials of similar density to that of host bone. On day 60, 
the defect was not totally obliterated by newly grown bony 
tissue. On day 90, radiographs showed that the defect was 
similar to what was observed after day 60, except that the 
newly formed bony tissue was more organized and the 
fractured end became smooth and round. Representative 
radiographs are shown in Fig. 3.
  Radiographs obtained on day 0 of group II (HAp) of the 
defect site showed a rectangular-shape mid-shaft diaphyseal 
defect with a well-placed HAp block and a radio-density of 
the implant, similar to that of the host bone. On day 21, the 
diagram showed a well-established periosteal reaction with 
narrowing of the gap between the bone and implant without 
any signs of implant resorption. On day 30, the radiographs 
showed the presence of the implant and radiologically- 
detectable newly grown host tissue. On day 60, the implant 
was noted to have a reduced density in comparison to the 
radiographs of previous days. On day 90, there was complete 
bridging of the cortical defect along the axis of the radius 
with a similar radio-dense bony material to that of normal 
bone. The presence of the implant could be identified by a 
radio-dense shadow in the implanted site and the implant 
was not absorbed, rather it had undergone structural changes 
by a host graft interaction. Representative radiographs are 
shown in Fig. 4.
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Fig. 5. Histologic sections of the control site. (A) The section 
showed an adequate amount of marrow material, fat cells, and 
blood vessels, along with a lamellar appearance of bone in the 
cortical area of the control bone. H&E stain, ×10. (B) The section
showed the presence of woven bone at the cortex of the control 
bone. Woven bone (white arrows), Haversian canal (black arrow-
head),  Haversian system (white arrowhead), new bone (white ar-
row with dotted line) and  host bone (black arrow). H&E stain, ×45.
Fig. 6. Histologic sections of the HAp-implanted bone. (A) The
section showed well-developed Haversian canals with defined 
osteoblasts at the periphery along with the presence of non-ab-
sorbed materials. H&E stain, × 10. (B) Histologic section 
showed well-developed lamellar bone (black arrowhead). 
Cortical area along with unabsorbed biodegradable material as a 
refractile crystalloid body (black arrow).  New bone (white ar-
row) and host bone (black arrow with dotted line). H&E stain, 
×45. 
Fig. 7. Photomicrograph showing the presence of homogenous 
non-fluoroscent area of cancellous bone at the defect site.  New
bone (arrows) and host bone (arrowheads). ×63.
Fig. 8. Photomicrograph on day 90 showing presence of fluo-
rescent osteoid tissue in the interspace of the HAp implant.  New
bone (arrows) and host bone (arrowhead). ×63. 
Histological study
  Tissue sections from group I (control) showed mild 
inflammatory reactions with moderate fibro-collagenization. 
The cortex showed a lamellar appearance of the bone along 
with the presence of woven bone in some places. The 
marrow space showed an adequate amount of marrow 
material, fat cells, and blood vessels (Figs. 5A and B).  
  Tissue sections of group II (HAp) showed complete normal 
ossification with development of Haversian canals and 
well-defined osteoblasts at the periphery. The blood vessels 
in the Haversian spaces were well-developed. The marrow 
space showed development of blood vessels with very little 
amount of marrow material. Non-absorbed biodegradable 
material was also noted in the lamellar cortical bone and in 
the marrow space as a refractile, crystalloid structure (Figs. 
6A and B).
Oxytetracycline labeling study
  In group I (control), the process of new bone formation was 
active from both ends. Newly formed osseous tissues 
originating from the periosteal, as well as the endosteal, 
surface of the bone were seen, however, the intensity was 
dominant on the periosteal side. The defect was completely 
filled with newly formed cancellous bone and appeared as a 
homogenous non-fluorescent area. However, a narrow linear 
zone near the periosteum revealed a golden-yellow fluorescence, 
suggestive of new bone formation in the area (Fig. 7). Union 
in the defect site of the bone was complete in most of the 
animals.
  In group II (HAp) under fluorescent microscopy, the defect 
line was visualized as a line of golden-yellow fluorescence, 
whereas the host bone evinced a dark, sea green homogenous 
colour. In this group, the activity of new bone formation was 
moderate. Within this new osteoid tissue, which completely 
filled the bone defect; crossing-over of the new bone 
trabeculae was evident. Resorption cavities were present, 
indicating that the resorption and replacement of bone were 
well under progress (Fig. 8).
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Fig. 10. Lateral (A) and anteroposterior (B) view of angiography
adjacent to the HAp implant.
Fig. 9. Angiograph on day 90 showing well-established medul-
lary cavity and uniform capillary network containing radio-dense
dye adjacent to the created defect.
Angiographic study
  Angiograms of the animals in group I (control) showed that 
there was uniform angiogenesis in the defect site. Establi-
shment of trans-transplant angiogenesis was evidenced by 
the presence of a capillary network on and around the defect 
site containing radio-dense contrast material. The angiogram 
also revealed the establishment of a uniform medullary 
cavity (Fig. 9). 
  Angiograms of group II (HAp) on day 90 postoperatively 
revealed the presence of intact radio-dense transplant 
material with a slight alteration of shape and size. There was 
completion of trans-transplant shunting of blood vessel 
communication which was well-depicted due to the presence 
of the positive contrast used during angiography. The lateral 
radiograph of the same animal also revealed that there were 
well-established, regularly arranged blood vessels in the 
periphery of the transplant (Fig. 10).
Discussion
  Bone grafts are often necessary to provide support, fill 
voids, and enhance biologic repair of skeletal defects. 
Strategies for the development of biologic substitutes 
capable of mimicking the natural environment aim to 
provide the key components which play a pivotal role in the 
repair of the bone [6,40]. Autogenous bone is the gold 
standard that all alternatives must meet or exceed. However, 
autografts have significant limitations; including donor site 
morbidity, inadequate availability, and inappropriate form 
[3,9,36]. These limitations have prompted increasing 
interest in alternative bone grafts. In recent years, con-
siderable strides have been made with the use of ceramics/ 
polymers in orthopedic surgery, particularly as permanent 
implants or joint replacement. The incorporation of these 
materials in host bone is clearly inferior to autogenous bone 
grafts. They enhance osteoconduction, which is a three- 
dimensional process of the growth of the capillaries, 
perivascular tissue, and osteoprogenitor cells of the host into 
the graft [15]. 
  In the present study, clinical signs were of little importance 
in evaluating the process of healing after reconstruction of 
bone defects by different types of implants. However, the 
type of wound healing and restoration of function provided a 
rough idea about the status of soft tissue and bone healing. In 
all the surgically-created defect areas, the implants were 
well-placed, well-accepted, and tolerated by the animals, 
causing no significant inflammation in the surrounding 
tissues. Healing was uneventful in all animals and there was 
no evidence of rejection of the implant in any case. The 
clinical features of the present study corroborated the 
findings of Holmes et al. [18]. Lameness gradually resolved, 
suggesting that the inflammation had subsided and the 
fracture was stabilizing, which corroborated the findings of 
ulnar fractures in dogs [32] and rabbits [35]. No foreign body 
response or toxicity was elicited and hence all the implants 
were accepted as a suitable alternative bone graft to fill the 
defect.
  Critical evaluation of radiographs taken at different 
intervals in the animals of group I revealed moderate 
evidence of fracture union as compared to the other group. 
However, in the initial stages, minimal periosteal reactions 
and smoothing edges of the cortical bone defects were 
noticed. This may be due to the larger defect size, which is in 
agreement with the observations of Singh [35]. Subsequently, 
there was a substantial reduction of gap size by newly 
formed osseous tissue, making the defect more round and 
smooth. A similar finding has also been reported by other 
workers [4].
  In the animals of group II, day 0 radiographs revealed the 
presence of well-placed HAp blocks in the mid-shaft radial 
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diaphyseal defects which were indistinguishable to the 
radio-density of host bone [35]. On day 21, there were 
well-established periosteal reactions without any signs of 
implant resorption. On day 30, the HAp implants were in the 
process of resorption from all four corners and the HAp 
implants were replaced by radiologically-detectable newly 
grown bone, which is in agreement with other observations 
[35]. On day 60, the cortex of the defect along the 
longitudinal axis was bridged with newly formed bony 
tissue, indicating a well-organized healing process. Com-
plete bridging of the cortical defect was observed on day 90 
with similar radio-dense bony material and the implant was 
encapsulated. It has been reported that 52.7% of the bone 
defect is replaced by lamellar bone and 27.5% of the HAp 
implant degraded within 24 weeks [30]. With the increase of 
pore size, the rate of resorption and replacement of this 
implant by the new bone also increased [11]. Besides, a 
change in surface area seemed to be the greatest factor 
affecting the rate of resorption of HAp ceramics [29]. The 
present results indicate that the pore size of the HAp implant 
was not optimum for ingrowths of new bone and hence the 
indication of slow resorption. 
  In group I, there was moderate fibro-collagenisation with 
the presence of woven bone in some places. The new bone 
formation was not sufficient to fill the entire defect, although 
marrow space showed an adequate amount of marrow 
materials and blood vessels, which supported the findings of 
other workers [4,14,35]. However, this was in contrast with 
the observations of Bolander and Balian [4], who reported 
that ungrafted ulnae did not successfully heal across the 
defect and there was a limited amount of new bone formation 
in the vicinity of the cut end of the defect.
  In group II, the bone defect was almost repaired with newly 
formed osteoid tissue with well-developed blood vessels in 
Haversian canals and a very small amount of marrow 
materials sparingly appeared at places, which corroborated 
the findings of other observations where Hap was implanted 
in the skulls of rats and skulls and ulnae of rabbits [35,39]. In 
these cases, the porous HAp acted as a scaffold for the 
in-growth of vessels and subsequent deposition of new bone, 
which is in agreement with the observation of Simmons [33] 
and Alexander et al. [1].
  There are several methods to examine newly formed bone 
using specific bone markers and labeling techniques [21]. 
The tetracycline labeling method was introduced to measure 
the exact quantity of newly formed bone as the tetracycline 
molecule has a fluorescence property in ultraviolet light. 
Oxytetracycline is absorbed to the areas where active 
deposition of mineralized tissue is taking place [13]. The 
labeled new bone and old bone emit bright golden-yellow 
and dark, sea green fluorescence, respectively, when viewed 
under UV light and this provides useful information in 
assessing the amount of new bone formation and fracture 
healing [25]. In the present study, oxytetracycline labelling 
(50 mg/kg body weight; a 2-6-2 pattern) before the end of the 
study was sufficient to quantify the extent of new bone 
formation at the implanted site of bone. 
  In animals of group I, most of the bone defects were 
occupied by a homogenous, non-fluoroscent area, indicating 
little new-bone formation, although the site and the process 
of new bone formation was active from both ends [35]. 
Newly formed bony tissue originated more from the 
periostial surface as compared to the endosteal side, 
indicating bony union at the defect site and suggesting a 
normal healing process. These findings simulated the 
observation in which two anabolic hormones were used in 
tibial fracture healing in dogs [37]. However, golden-yellow 
fluorescence was seen in a narrow linear zone near the 
periosteum, suggesting new bone formation in the area.
  The oxytetracycline labeling study demonstrated that new 
bone formation in the defect site was greater in group II 
compared to group I animals. There was little indication of 
implant contribution towards new bone formation, rather a 
contribution mainly by the host bone, which is in agreement 
with the observations of other workers [35]. Resorption 
cavities were present in Hap-implanted bone, suggesting that 
the resorption, remodeling, and replacement of the bone 
were well underway. 
  Sodium iothalmate, as a contrast media, has been suc-
cessfully used for the visualization of different vascular 
patterns [41]. Lead oxide soap suspension (20%), as a 
contrast media, was found satisfactory for the visualization 
of major arteries and also minute vascular branches [26]. 
This material is toxic, cannot be drained out by the venous 
system, and as such, the animal must be sacrificed before 
performing angiography.
  Critical evaluation of angiographic results of the present 
study revealed varying degrees of vascularization. However, 
the evidence of trans-transplant angiogenesis was more 
pronounced in animals implanted with HAp than the 
controls. The presence of intact transplant material that was 
detected by angiography could be attributed to the fact that 
the transplant was biocompatible and subsequently had low 
or no inflammatory response, which was also observed by 
Singh [34]. The minute vessels of periosteal and endosteal 
origin invadidng the implant bed supports the view that 
vascularization in fracture healing is directly related to the 
amount of new bone formation [7]. Angiograms of control 
animals revealed comparatively less uniform trans- 
transplant angiogenesis, although the medullary cavity was 
well-established. 
  In conclusion, nano-HAp powders prepared by a novel 
aqueous solution combustion technique, is a very simple 
method by which not only the powder size, but the 
composition can also be varied for optimum osteoinductive 
and conductive responses in vivo. Porous HAp ceramic 
material promoted bone formation over the defect, con-
forming their biologic osteoconductive property. No inflam-
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matory reaction was observed due to the presence of the 
implanted material. This has been interpreted and subseq-
uently verified from the experimental results in terms of 
radiologic and histopathologic methods, angiography, as 
well as the oxytetracycline labeling studies.
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